Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170364 · ClinicalTrials.gov registry record · Phase 4
Studying the Effects of Sibutramine on Eating Behavior
A Phase 4 study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT01170364 is a Phase 4 study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 14 participants.
The verdict
NCT01170364, a Phase 4 study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
Obesity is a major public health concern, and the search for useful pharmacologic interventions is ongoing. This study aims to develop a comprehensive series of assessments to directly assess eating behavior, cognitive functioning, and psychological functioning under sibutramine and placebo conditions.
Interventions
- DRUG Placebo
- DRUG Sibutramine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01170364
The ClinicalTrials.gov registry entry for NCT01170364 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01170364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01170364 about?
NCT01170364 is a clinical study titled "Studying the Effects of Sibutramine on Eating Behavior". Obesity is a major public health concern, and the search for useful pharmacologic interventions is ongoing. This study aims to develop a comprehensive series of assessments to directly assess eating behavior, cognitive functioning, and psychological functioning under sibutramine and placebo conditio...
What is the current status of trial NCT01170364?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2009-02. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01170364?
The interventions under investigation include: Placebo (DRUG), Sibutramine (DRUG).
Who is sponsoring clinical trial NCT01170364?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.